GP-Act III Acquisition Corp.
No SEC Form 4 filings for $GPAT in the last 30 days.
See all $GPAT insider activity →GP-Act III Acquisition Corp. (GPAT) reported net income of $2.44M for the six months ended June 30, 2026, driven by $4.48M interest on Trust investments, partly offset by $2.03M G&A. Assets were $98.4M, mainly $98.2M in the Trust after redemptions. Management disclosed substantial doubt about going concern due to tight non-Trust liquidity and a Nov. 13, 2026 liquidation deadline.
GP-Act III Acquisition Corporation (GPAT) is seeking shareholder approval to extend its business combination and trust liquidation deadlines from May to November 2026. The company plans to use non-redemption agreements with third-party shareholders to secure votes for the extension and preserve cash in the SPAC trust, aiming to facilitate a future business combination. These agreements are designed to stabilize the capital base and ensure sufficient funds for the transaction.
GP-Act III Acquisition Corporation (GPAT) adjourned its extraordinary general meeting on April 29 to May 6, seeking shareholder approval to extend its business combination and trust liquidation deadlines. This extension, from May 13 to November 13, 2026, would provide the SPAC more time to finalize a deal and preserve shareholder value. The company also allowed investors to reverse previous redemption requests, aiming to maintain its cash position.
Over the past 7 days, alphai's AI scored 1 news story mentioning GPAT (GP-Act III Acquisition Corp.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent GPAT coverage spans financial news and corporate actions.
Going-concern language and tight liquidity increase liquidation risk and reduce the probability of a timely business combination, typically pressuring SPAC units/shares.
The proposed extension and use of non-redemption agreements aim to stabilize GPAT's capital base, potentially facilitating a successful future business combination.
The company's decision to seek extension and allow investors to reverse redemptions indicates an attempt to preserve shareholder value and complete a potential acquisition. This could be viewed positively by investors valuing stability and deal continuity.
GPAT shows a neutral sentiment with a sentiment score of 0.055273, suggesting limited market impact from recent news.
alphai scores every news story that mentions GPAT with an AI model for sentiment and relevance, and aggregates insider trades from GP-Act III Acquisition Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
GP-Act III Acquisition Corp. (GPAT) reported net income of $2.44M for the six months ended June 30, 2026, driven by $4.48M interest on Trust investments, partly offset by $2.03M G&A. Assets were $98.4M, mainly $98.2M in the Trust after redemptions. Management disclosed substantial doubt about going concern due to tight non-Trust liquidity and a Nov. 13, 2026 liquidation deadline.
4 min readGP-Act III Acquisition Corporation (GPAT) is seeking shareholder approval to extend its business combination and trust liquidation deadlines from May to November 2026. The company plans to use non-redemption agreements with third-party shareholders to secure votes for the extension and preserve cash in the SPAC trust, aiming to facilitate a future business combination. These agreements are designed to stabilize the capital base and ensure sufficient funds for the transaction.
3 min readGP-Act III Acquisition Corporation (GPAT) adjourned its extraordinary general meeting on April 29 to May 6, seeking shareholder approval to extend its business combination and trust liquidation deadlines. This extension, from May 13 to November 13, 2026, would provide the SPAC more time to finalize a deal and preserve shareholder value. The company also allowed investors to reverse previous redemption requests, aiming to maintain its cash position.
2 min readM3-Brigade Acquisition V (MBAV) is a SPAC with a market cap of US$383.8 million, primarily focused on effecting business combinations as it does not have significant operations. The company recently announced a $1 billion reverse merger agreement with ReserveOne Inc. and has received funding updates. MBAV has shown stable share price volatility compared to the US market but has underperformed the broader US Market over the past year, while exceeding the US Capital Markets industry.
3 min read
